Estudos de relação estrutura atividade e docking - UFRJ

94STIERAND, K.; RAREY, M. Drawing the PDB: Protein−Ligand Complexes in Two Dimensions. ACS MedChem Lett, v. 1, 9, p. 540-545, 2010.TAYLOR, R. D.; JEWSBURY, P. J.; ESSEX, J. W. A review of protein-small molecule docking methods. JComput Aided Mol Des, v. 16, 3, p. 151-66, 2002.TERAMOTO, R.; FUKUNISHI, H. Supervised consensus scoring for docking and virtual screening. J ChemInf Model, v. 47, 2, p. 526-34, 2007.TONG, L. Viral proteases. Chem Rev, v. 102, 12, p. 4609-26, 2002.TONG, L.; QIAN, C.; MASSARIOL, M. J.; BONNEAU, P. R.; CORDINGLEY, M. G.; LAGACE, L. A newserine-protease fold revealed by the crystal structure of human cytomegalovirus protease. Nature, v. 383, 6597,p. 272-5, 1996.TOSTES, J. G. Estrutura molecular: o conceito fundamental da química. Química Nova na Escola, v. 7, p. 17-20, 1998.TURNER, G. W.; TEDESCO, E.; HARRIS, K. D. M.; JOHNSTON, R. L.; KARIUKI, B. M. Implementation ofLamarckian concepts in a Genetic Algorithm for structure solution from powder diffraction data. ChemicalPhysics Letters, v. 321, 3–4, p. 183-190, 2000.VERLI, H.; BARREIRO, E. J. Um paradigma da química medicinal: a flexibilidade dos ligantes e receptores.Química Nova, v. 28, p. 95-102, 2005.VIEIRA, M. R. Estudo da Biorredução de compostos carbonílicos por linhagens de Saccharomycescerevisae sp. (Mestrado). Centro de Ciências, Universidade Regional de Blumenal, Blumenau, 2006.WATANABE, D. Medical application of herpes simplex virus. J Dermatol Sci, v. 57, 2, p. 75-82, 2010.WAXMAN, L.; DARKE, P. L. The herpesvirus proteases as targets for antiviral chemotherapy. Antivir ChemChemother, v. 11, 1, p. 1-22, 2000.WELCH, A. R.; MCNALLY, L. M.; HALL, M. R.; GIBSON, W. Herpesvirus proteinase: site-directedmutagenesis used to study maturational, release, and inactivation cleavage sites of precursor and to identify apossible catalytic site serine and histidine. J Virol, v. 67, 12, p. 7360-7372, 1993.WERMUTH, C. G. The Practice of Medicinal Chemistry. 2 ed ed., 2003.WILLIAMS, C. H.; HONG, C. C. Multi-step usage of in vivo models during rational drug design and discovery.Int J Mol Sci, v. 12, 4, p. 2262-74, 2011.YAN, A.; CHONG, Y.; WANG, L.; HU, X.; WANG, K. Prediction of biological activity of Aurora-A kinaseinhibitors by multilinear regression analysis and support vector machine. Bioorg Med Chem Lett, v. 21, 8, p.2238-43, 2011.ZENG, Q. H.; YU, A. B.; LU, G. Q. Multiscale modeling and simulation of polymer nanocomposites. Progressin Polymer Science, v. 33, 2, p. 191-269, 2008.